Organogenesis

is a Massachusetts-based regenerative medicine company that develops bioactive and acellular biomaterials products to treat orthopedics and spine diseases...
Read more
Organogenesis President & CEO: Gary S. Gillheeney Sr.

President & CEO

Gary S. Gillheeney Sr.

CEO Approval Rating

72/100

Annual Revenue
$482M
Employees
950
Funding
$557.4M
Acquisitions
3

Organogenesis Competitors

1Arthrex
2Integra LifeSciences
33M
4Medtronic
5MiMedx
6Smith & Nephew
7Misonix
8Stryker
9Alliqua
10Parexel

Trending Companies